Reading Time: < 1 minute

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – May 6, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased to announce that it is currently trading on the OTCQB Venture Market and is eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States. The Company’s common shares are quoted in the United States on the OTCQB Venture Market under the ticker symbol ” INNPF “.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/83139

Powered by WPeMatico